These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 25496432)

  • 1. Association between advanced oxidation protein products and 5-year mortality risk among amazon riparian elderly population.
    Silva TO; Jung IE; Moresco RN; Barbisan F; Ribeiro EE; Ribeiro EA; Motta K; Britto E; Tasch E; Bochi G; Duarte MM; Oliveira AR; Marcon M; Belló C; dos Santos Montagner GF; da Cruz IB
    Free Radic Res; 2015 Feb; 49(2):204-9. PubMed ID: 25496432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accumulation of circulating advanced oxidation protein products is an independent risk factor for ischaemic heart disease in maintenance haemodialysis patients.
    Zhou Q; Wu S; Jiang J; Tian J; Chen J; Yu X; Chen P; Mei C; Xiong F; Shi W; Zhou W; Liu X; Sun S; Xie DI; Liu J; Xu X; Liang M; Hou F
    Nephrology (Carlton); 2012 Sep; 17(7):642-9. PubMed ID: 22738256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased plasma levels of advanced oxidation protein products (AOPP) as a marker for oxidative stress in patients with active ulcerative colitis.
    Alagozlu H; Gorgul A; Bilgihan A; Tuncer C; Unal S
    Clin Res Hepatol Gastroenterol; 2013 Feb; 37(1):80-5. PubMed ID: 22572519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further evidence of inflammation in chronic rheumatic valve disease (CRVD): high levels of advanced oxidation protein products (AOPP) and high sensitive C-reactive protein (hs-CRP).
    Chiu-Braga YY; Hayashi SY; Schafranski M; Messias-Reason IJ
    Int J Cardiol; 2006 May; 109(2):275-6. PubMed ID: 15946754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased level of advanced oxidation products (AOPP) as a marker of oxidative stress in patients with acute coronary syndrome.
    Skvarilová M; Bulava A; Stejskal D; Adamovská S; Bartek J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Jun; 149(1):83-7. PubMed ID: 16170393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ischemia-modified albumin and advanced oxidation protein products as potential biomarkers of protein oxidation in Alzheimer's disease.
    Altunoglu E; Guntas G; Erdenen F; Akkaya E; Topac I; Irmak H; Derici H; Yavuzer H; Gelisgen R; Uzun H
    Geriatr Gerontol Int; 2015 Jul; 15(7):872-80. PubMed ID: 25345484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overestimation of advanced oxidation protein products in uremic plasma due to presence of triglycerides and other endogenous factors.
    Valli A; Suliman ME; Meert N; Vanholder R; Lindholm B; Stenvinkel P; Watanabe M; Barany P; Alvestrand A; Anderstam B
    Clin Chim Acta; 2007 Apr; 379(1-2):87-94. PubMed ID: 17292872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced oxidation protein product level in children with chronic otitis media with effusion.
    Balıkcı HH; Karakaş M; Gürdal MM; Ozkul MH; Bayram O; Bayram AA; Yigit S
    Int J Pediatr Otorhinolaryngol; 2014 Mar; 78(3):551-3. PubMed ID: 24491806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlation between the serum level of advanced oxidation protein products and the cognitive function in patients with obstructive sleep apnea hypopnea syndrome].
    Yang XH; Liu X; Shang J; Liu HG; Xu YJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Apr; 36(4):274-9. PubMed ID: 23945341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of AOPP in Age-Related Bone Loss and the Potential Benefits of Berry Anthocyanins.
    Melough MM; Sun X; Chun OK
    Nutrients; 2017 Jul; 9(7):. PubMed ID: 28737666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced oxidation protein products and malondialdehyde - the new biological markers of oxidative stress - are elevated in postmenopausal women.
    Cakir T; Goktas B; Mutlu MF; Mutlu I; Bilgihan A; Erdem M; Erdem A
    Ginekol Pol; 2016; 87(5):321-5. PubMed ID: 27304645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in the behavior of advanced glycation end products and advanced oxidation protein products in patients with allergic rhinitis.
    Di Lorenzo G; Minciullo PL; Leto-Barone MS; La Piana S; La Porta G; Saija A; Gangemi S
    J Investig Allergol Clin Immunol; 2013; 23(2):101-6. PubMed ID: 23654076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levels of renalase and advanced oxidation protein products with regard to catecholamines in haemodialysed patients.
    Dziedzic M; Orłowska E; Petkowicz B; Bednarek-Skublewska A; Solski J; Goździewska M
    Ann Agric Environ Med; 2017 Sep; 24(3):453-458. PubMed ID: 28954489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of advanced oxidative protein products in human saliva and plasma: age- and gender-related changes and stability during storage.
    Qing Z; Ling-Ling E; Dong-Sheng W; Hong-Chen L
    Free Radic Res; 2012 Oct; 46(10):1201-6. PubMed ID: 22671992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malondialdehyde and advanced oxidation protein products are not increased in psoriasis: a controlled study.
    Skoie IM; Dalen I; Omdal R; Jonsson G
    Arch Dermatol Res; 2019 May; 311(4):299-308. PubMed ID: 30830309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased advanced oxidation protein products in Behçet's disease: a new activity marker?
    Yazici C; Köse K; Caliş M; DemIr M; Kirnap M; Ateş F
    Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human blood plasma advanced oxidation protein products (AOPP) correlates with fibrinogen levels.
    Selmeci L; Székely M; Soós P; Seres L; Klinga N; Geiger A; Acsády G
    Free Radic Res; 2006 Sep; 40(9):952-8. PubMed ID: 17015275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of nitrate, nitrite and advanced oxidation protein products (AOPP) in patients with nonalcoholic fatty liver disease.
    Çiftci A; Yilmaz B; Köklü S; Yüksel O; Özsoy M; Erden G; Öztürk G; Akbal E; Ergül B; Koçak E; Cesur S
    Acta Gastroenterol Belg; 2015 Jun; 78(2):201-5. PubMed ID: 26151688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced oxidation protein products in nondiabetic end stage renal disease patients on maintenance haemodialysis.
    Colombo G; Reggiani F; Astori E; Altomare A; Finazzi S; Garavaglia ML; Angelini C; Milzani A; Badalamenti S; Dalle-Donne I
    Free Radic Res; 2019 Dec; 53(11-12):1114-1124. PubMed ID: 31755327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced oxidation protein products are generated by bovine neutrophils and inhibit free radical production in vitro.
    Bordignon M; Da Dalt L; Marinelli L; Gabai G
    Vet J; 2014 Jan; 199(1):162-8. PubMed ID: 24291143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.